IL33 and neoplasm: However, because IL-33-ST2L signaling is modulated by the amount of sST2 and microarray analyses measure only ST2L or do not draw a distinction between ST2L and sST2, we thought that evaluating the effect of sST2 released from cancer cells during tumor growth is important for proper prognostic analyses.